US 10286036
Protocol for treatment of lupus nephritis
granted A61KA61K31/365A61K31/573
Quick answer
US patent 10286036 (Protocol for treatment of lupus nephritis) held by AURINIA PHARMACEUTICALS INC. expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AURINIA PHARMACEUTICALS INC.
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/365, A61K31/573, A61K38/13, A61P